Revolutionizing Gut Health: The Power of Synbiotics

CSN Pharma is dedicated to advancing the field of human gut microbiome research, exploring various nutraceutical categories that promote optimal health and well-being. As we continue our journey of discovery, synbiotics have emerged as a promising area of research within this expanding field.

According to the International Scientific Association for Probiotics and Prebiotics (ISAPP), synbiotics are defined as a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms, conferring a health benefit on the host.

We recognize the importance of well-established prebiotics such as Galactooligosaccharides (GOS), fructooligosaccharides (FOS), and inulin, backed by over 30 years of research. These prebiotics have proven efficacy in promoting gut health and supporting overall well-being. CSN Pharma is committed to incorporating these established prebiotics into our specified strain  formulations to offer effective solutions that improve the efficacy of the product and, meet the needs of our customers.

Additionally, CSN Pharma continues to explore and evaluate other substances, including oligosaccharides, phenolics, phytochemicals, conjugated linoleic acid, and polyunsaturated fatty acids, to uncover their potential prebiotic activity. Our ongoing research efforts allow us to expand our knowledge and consider the inclusion of new ingredients that may enhance gut health in future product development.

As a leading manufacturer in the nutraceutical industry located in beautiful British Columbia, CSN Pharma remains dedicated to providing innovative solutions that prioritize quality, scientific rigor, and customer well-being. We invite you to stay connected with us as we explore and introduce new developments aligned with the evolving science of gut health.